Video
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus